|
CEL-SCI Corporation Prices $6 Million Public Offering of Common Stock and …
PharmiWeb.com (press release) CEL-SCI Corporation (NYSE MKT: CVM) a late-stage oncology company today announced that it has priced a “best efforts” underwritten public offering of common stock and warrants at a combined price of $0.76 for aggregate gross proceeds of $6 million … CEL-SCI To Raise $1 Mln In Registered Direct Offering – Quick FactsNASDAQ |
